Patents by Inventor Takuya Tamatani

Takuya Tamatani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cell surface molecule mediating cell adhesion and signal transmission
    Publication number: 20040151718
    Abstract: Novel cell surface molecules recognized by monoclonal antibodies against a cell surface molecule of lymphocytic cells that play an important role in autoimmune diseases and allergic diseases have been isolated, identified, and analyzed for their functions. The cell surface molecules are expressed specifically in thymocytes, lymphocytes activated by ConA-stimulation, and peripheral blood lymphocytes, and induce cell adhesion. Antibodies against the cell surface molecules significantly ameliorate pathological conditions of autoimmune diseases and allergic diseases.
    Type: Application
    Filed: November 7, 2003
    Publication date: August 5, 2004
    Applicant: Japan Tobacco Inc. a Japananese corporation
    Inventors: Takuya Tamatani, Katsunari Tezuka
  • Cell surface molecule mediating cell adhesion and signal transmission
    Publication number: 20040151669
    Abstract: Novel cell surface molecules recognized by monoclonal antibodies against a cell surface molecule of lymphocytic cells that play an important role in autoimmune diseases and allergic diseases have been isolated, identified, and analyzed for their functions. The cell surface molecules are expressed specifically in thymocytes, lymphocytes activated by ConA-stimulation, and peripheral blood lymphocytes, and induce cell adhesion. Antibodies against the cell surface molecules significantly ameliorate pathological conditions of autoimmune diseases and allergic diseases.
    Type: Application
    Filed: March 11, 2004
    Publication date: August 5, 2004
    Applicant: Japan Tobacco, Inc., a Japan corporation
    Inventors: Takuya Tamatani, Katsunari Tezuka
  • Antibodies specific for a cell surface molecule mediating cell adhesion and signal transmission, cells secreting such antibodies, and methods of making and using such antibodies
    Publication number: 20040146506
    Abstract: Novel cell surface molecules recognized by monoclonal antibodies against a cell surface molecule of lymphocytic cells that play an important role in autoimmune diseases and allergic diseases have been isolated, identified, and analyzed for their functions. The cell surface molecules are expressed specifically in thymocytes, lymphocytes activated by ConA-stimulation, and peripheral blood lymphocytes, and induce cell adhesion. Antibodies against the cell surface molecules significantly ameliorate pathological conditions of autoimmune diseases and allergic diseases.
    Type: Application
    Filed: November 7, 2003
    Publication date: July 29, 2004
    Applicant: Japan Tobacco Inc., a Japanese corporation
    Inventors: Takuya Tamatani, Katsunari Tezuka
  • Cell surface molecule mediating cell adhesion and signal transmission
    Publication number: 20040132658
    Abstract: Novel cell surface molecules recognized by monoclonal antibodies against a cell surface molecule of lymphocytic cells that play an important role in autoimmune diseases and allergic diseases have been isolated, identified, and analyzed for their functions. The cell surface molecules are expressed specifically in thymocytes, lymphocytes activated by ConA-stimulation, and peripheral blood lymphocytes, and induce cell adhesion. Antibodies against the cell surface molecules significantly ameliorate pathological conditions of autoimmune diseases and allergic diseases.
    Type: Application
    Filed: November 7, 2003
    Publication date: July 8, 2004
    Applicant: Japan Tobacco Inc., a Japanese corporation
    Inventors: Takuya Tamatani, Katsunari Tezuka
  • Cell surface molecule mediating cell adhesion and signal transmission
    Publication number: 20040120945
    Abstract: Novel cell surface molecules recognized by monoclonal antibodies against a cell surface molecule of lymphocytic cells that play an important role in autoimmune diseases and allergic diseases have been isolated, identified, and analyzed for their functions. The cell surface molecules are expressed specifically in thymocytes, lymphocytes activated by ConA-stimulation, and peripheral blood lymphocytes, and induce cell adhesion. Antibodies against the cell surface molecules significantly ameliorate pathological conditions of autoimmune diseases and allergic diseases.
    Type: Application
    Filed: November 25, 2003
    Publication date: June 24, 2004
    Applicant: Japan Tobacco Inc., a Japanese corporation
    Inventors: Takuya Tamatani, Katsunari Tezuka
  • Antibodies specific for a cell surface molecule mediating cell adhesion and signal transmission, cells secreting such antibodies, and methods of making and using such antibodies
    Publication number: 20040073012
    Abstract: Novel cell surface molecules recognized by monoclonal antibodies against a cell surface molecule of lymphocytic cells that play an important role in autoimmune diseases and allergic diseases have been isolated, identified, and analyzed for their functions. The cell surface molecules are expressed specifically in thymocytes, lymphocytes activated by ConA-stimulation, and peripheral blood lymphocytes, and induce cell adhesion. Antibodies against the cell surface molecules significantly ameliorate pathological conditions of autoimmune diseases and allergic diseases.
    Type: Application
    Filed: November 7, 2003
    Publication date: April 15, 2004
    Applicant: Japan Tobacco Inc., a Japanese corporation
    Inventors: Takuya Tamatani, Katsunari Tezuka
  • Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
    Publication number: 20030166011
    Abstract: A human monoclonal antibody useful for the treatment of various diseases caused by human connective tissue growth factor (CTGF) and preventing the onset of the above diseases; medicinal uses thereof; and various monoclonal antibodies having various characteristics against various mammalian CTGFs useful for detecting and assaying CTGFs present in body fluids of mammals suffering from various diseases.
    Type: Application
    Filed: March 17, 2003
    Publication date: September 4, 2003
    Inventors: Takuya Tamatani, Katsunari Tezuka, Shinji Sakamoto, Masaharu Takigawa
  • Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
    Patent number: 6562618
    Abstract: A human monoclonal antibody useful for the treatment of various diseases caused by human connective tissue growth factor (CTGF) and preventing the onset of the above diseases; medicinal uses thereof; and various monoclonal antibodies having various characteristics against various mammalian CTGFs useful for detecting and assaying CTGFs present in body fluids of mammals suffering from various diseases.
    Type: Grant
    Filed: September 18, 2000
    Date of Patent: May 13, 2003
    Assignees: Japan Tobacco, Inc., Nichirei Corporation
    Inventors: Takuya Tamatani, Katsunari Tezuka, Shinji Sakamoto, Masaharu Takigawa
  • Cell surface molecule mediating cell adhesion and signal transmission
    Publication number: 20030083472
    Abstract: Novel cell surface molecules recognized by monoclonal antibodies against a cell surface molecule of lymphocytic cells that play an important role in autoimmune diseases and allergic diseases have been isolated, identified, and analyzed for their functions. The cell surface molecules are expressed specifically in thymocytes, lymphocytes activated by ConA-stimulation, and peripheral blood lymphocytes, and induce cell adhesion. Antibodies against the cell surface molecules significantly ameliorate pathological conditions of autoimmune diseases and allergic diseases.
    Type: Application
    Filed: November 21, 2002
    Publication date: May 1, 2003
    Applicant: Japan Tobacco Inc., a Japanese corporation
    Inventors: Takuya Tamatani, Katsunari Tezuka
  • Cell surface molecule mediating cell adhesion and signal transmission
    Publication number: 20020156242
    Abstract: Novel cell surface molecules recognized by monoclonal antibodies against a cell surface molecule of lymphocytic cells that play an important role in autoimmune diseases and allergic diseases have been isolated, identified, and analyzed for their functions. The cell surface molecules are expressed specifically in thymocytes, lymphocytes activated by ConA-stimulation, and peripheral blood lymphocytes, and induce cell adhesion. Antibodies against the cell surface molecules significantly ameliorate pathological conditions of autoimmune diseases and allergic diseases.
    Type: Application
    Filed: March 26, 2002
    Publication date: October 24, 2002
    Applicant: Japan Tobacco, Inc., a Japanese corporation
    Inventors: Takuya Tamatani, Katsunari Tezuka
  • Cell surface molecule mediating cell adhesion and signal transmission
    Publication number: 20020151685
    Abstract: Novel cell surface molecules recognized by monoclonal antibodies against a cell surface molecule of lymphocytic cells that play an important role in autoimmune diseases and allergic diseases have been isolated, identified, and analyzed for their functions. The cell surface molecules are expressed specifically in thymocytes, lymphocytes activated by ConA-stimulation, and peripheral blood lymphocytes, and induce cell adhesion. Antibodies against the cell surface molecules significantly ameliorate pathological conditions of autoimmune diseases and allergic diseases.
    Type: Application
    Filed: March 26, 2002
    Publication date: October 17, 2002
    Applicant: Japan Tobacco, Inc.
    Inventors: Takuya Tamatani, Katsunari Tezuka
  • Cell surface molecule mediating cell adhesion and signal transmission
    Publication number: 20020115831
    Abstract: Novel cell surface molecules recognized by monoclonal antibodies against a cell surface molecule of lymphocytic cells that play an important role in autoimmune diseases and allergic diseases have been isolated, identified, and analyzed for their functions. The cell surface molecules are expressed specifically in thymocytes, lymphocytes activated by ConA-stimulation, and peripheral blood lymphocytes, and induce cell adhesion. Antibodies against the cell surface molecules significantly ameliorate pathological conditions of autoimmune diseases and allergic diseases.
    Type: Application
    Filed: March 26, 2002
    Publication date: August 22, 2002
    Applicant: Japan Tobacco, Inc., a Japanese corporation
    Inventors: Takuya Tamatani, Katsunari Tezuka
  • Monoclonal antibody reactive to human CETP and assay method for human CETP
    Patent number: 6410020
    Abstract: Monoclonal antibodies which have binding specificity to human CETP(CETP inhibition activity) and which are useful as reagents for purification or quantification of human CETP, and as pharmaceuticals to prevent and/or treat hyperlipidemia or arteriosclerosis are provided. Furthermore, purification and quantification methods of human CETP by using the monoclonal antibodies are also provided.
    Type: Grant
    Filed: July 12, 2000
    Date of Patent: June 25, 2002
    Assignee: Japan Tobacco, Inc.
    Inventors: Masafumi Kamada, Hiroshi Okamoto, Takuya Tamatani
  • Monoclonal antibody reactive with human-origin CETP and method of quantifying human-origin CETP
    Patent number: 6140474
    Abstract: Monoclonal antibodies which have binding specificity to human CETP (CETP inhibition activity) and which are useful as reagents for purification or quantification of human CETP, and as pharmaceuticals to prevent and/or treat hyperlipidemia or arteriosclerosis are provided. Furthermore, purification and quantification methods of human CETP by using the monoclonal antibodies are also provided.
    Type: Grant
    Filed: October 31, 1997
    Date of Patent: October 31, 2000
    Assignee: Japan Tobacco, Inc.
    Inventors: Masafumi Kamada, Hiroshi Okamoto, Takuya Tamatani